3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
MMTC M Header 

Cambridge Healthtech Institute’s Sixth Annual 

Genome and Transcriptome Analysis   

Disease-Relevant Analysis of NGS 'Omics Data 

February 15-18, 2015 | Moscone North Convention Center | San Francisco, CA  
Part of the 22nd International Molecular Medicine Tri-Conference 


The analysis of 'omics data derived from various applications of next-generation sequencing (NGS) has and will continue to radically impact our fundamental understanding of disease biology. As researchers and clinicians more ably harness the power of sequencing technologies, the interrogation of individual and large cross-omics datasets provide broader views of underlying contributors of disease, and insights into the interconnectivity of our underlying genome, and the dynamic, regulatory epigenome and transcriptome. The Genome and Transcriptome Analysis meeting will once again explore how NGS is continuing to shape our understanding human disease, by uncovering biological meaning from analyzing NGS data.

Who should attend: Directors, Managers, Researchers, and Scientists from Pharma, Biotechs, Academia, Government and Healthcare Organizations working in fields such as Genomics, Epigenomics, Cell & Molecular Biology, Oncology, Basic and Clinical Research, Translational & Biomedical Informatics, Computational Biology, Bioinformatics& Data Management

Topics may include, but are not limited to: 

  • Novel findings in cancer genomics and epigenomics
  • Detection and function of novel NcRNAs 
  • Functional analysis of genome, transcriptome and epigenome data
  • Whole genome sequencing & data analysis
  • Single-cell genome and transcriptome sequencing and data analysis
  • Clinical-grade sequencing and data analysis
  • Computational genomics  
  • Utilization of open/public genomic data resources   
  • Integration, analysis, mining and visualization of NGS datasets
  • Data infrastructure and computing

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 18, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Kip Harry
Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5454
E: kharry@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z) 
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 



Premier Sponsors:

Leica Biosystems 





Jackson Laboratory - small logo